Nuhey News

We talk about the MARKET

Global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener Market: Drivers, Restrains& Forecasts to 2028

Cervical liquid-based cell artificial intelligence screening system Cervical-Sight utilizes deep learning technology based on convolutional neural network, which can realize automatic analysis of cervical liquid-based cell images, rapid screening and localization of diseased cells, and can detect diseased cells according to TBS guidelines. classification, and detection of microbial infections. Diagnosis is made through intelligent analysis, and finally a detection report is generated.

Due to the COVID-19 pandemic, the global Liquid-based Cell Cervical Cancer Artificial Intelligence Screener market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Liquid-based Cell Cervical Cancer Artificial Intelligence Screener market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Liquid-based Cell Cervical Cancer Artificial Intelligence Screener landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Request for a free sample or purchase this report at: https://www.themarketreports.com/report/global-liquid-based-cell-cervical-cancer-artificial-intelligence-screener-market-research-report

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Flow Cytometer
  • Blood Cell Analyzer

Segment by Application

  • Hospital
  • Clinic
  • Research Laboratory
  • Others

By Company

  • Hologic
  • Imsightmed
  • SenseTime
  • Landing Medical
  • Cells Vision Technology
  • BD
  • Jiulu Biotechnology
  • Guangzhou Anbiping Pharmaceutical Technology
  • Ingenuity System
  • Huayin Health
  • Mcaudi

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

 

Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479

Email: sales@themarketreports.com